Interferon gamma Blocker [EPC] - N0000193856

Pharmacologic Code	N0000193856
Pharmacologic Name	Interferon gamma Blocker
Pharmacologic Uses	interferon gamma (IFNγ) blocking antibody
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 7 products whose active ingredient are classified under the same pharmacologic class Interferon gamma Blocker [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	66658-501	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-505	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-510	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-522	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-523	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-524	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE
	66658-525	Gamifant	Non-Proprietary Name: Emapalumab-lzsg	Injection	Intravenous	Swedish Orphan Biovitrum Ab (publ)	ACTIVE